Important: Formulation and dosage details
Formulation:
Tablets 62·5mg, 125mg (specialist initiation only)
Dosage:
Pulmonary hypertension: initiation and prescribing are restricted to use under the guidance of the Scottish Pulmonary Vascular Unit with funding through the Scottish Board Chief Executive Drug Risk Share Scheme.